AZATHIOPRINE SODIUM FOR INJECTION DIN 02231575
Health Canada record
| Active ingredient(s) | AZATHIOPRINE (AZATHIOPRINE SODIUM) 100 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L04AX01 AZATHIOPRINE |
| Original market date | |
| Current status date | 16-Oct-2015 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AZATHIOPRINE (AZATHIOPRINE SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02244895 | IMURAN | ASPEN PHARMACARE CANADA INC. | Powder For Solution | AZATHIOPRINE (AZATHIOPRINE SODIUM) 50 MG | Dormant |
| 00337854 | IMURAN INJ 100MG | GLAXO WELLCOME INC. | Powder For Solution | AZATHIOPRINE (AZATHIOPRINE SODIUM) 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 3296 | 1997-06-24 | Abbreviated New Drug Submission (ANDS) |